Medicine
Sodium nitroprusside 50 mg/2 mL injection
Sodium nitroprusside 50 mg/2 mL injection is a generic prescription medicine for intravenous use, made by 12 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). To protect Sodium Nitroprusside Injection…
Key facts
- Active ingredient (INN)
- Sodium nitroprusside
- Brand
- Sold under the generic name
- Strength
- 50 mg/2 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 vial of 2 mL and 11 more
- Manufacturers
- Dr. Reddy's LaboratoriesIndiaAuroMedics PharmaIndiaCaplin SterilesIndiaMicro LabsIndiaMylan InstitutionalAmneal PharmaceuticalsArmas PharmaceuticalsBE PharmaceuticalsHainan Poly PharmMeitheal Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). To protect Sodium Nitroprusside Injection from light, it should be stored in its carton until it is used.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 7 November 2017
- Identifiers
- RxCUI 240793DailyMed set ID 41e11afb-5fa4-4212-889d-1092dbd0702a, 5a689f89-3cbd-f9fa-13cc-26063feb9c83, 2122b9c1-0af4-493b-82cc-63eee02f987f +11NDC 55150-320, 43598-587, 70069-261 +11Application ANDA211934, ANDA210114, ANDA210882 +6
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 43598-587-23 | Dr. Reddy's LaboratoriesIndia | 17 December 2019 |
| 1 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 75907-290-11 | Dr. Reddy's LaboratoriesIndia | 1 December 2025 |
| 1 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 55150-320-01 | AuroMedics PharmaIndia | 10 December 2020 |
| 1 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 65145-101-01 | Caplin SterilesIndia | 29 October 2025 |
| 1 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 42571-265-75 | Micro LabsIndia | 30 December 2017 |
| 1 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 67457-839-02 | Mylan Institutional | 10 August 2018 |
| 1 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 67457-999-02 | Mylan Institutional | 5 October 2020 |
| 1 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 70121-1189-1 | Amneal Pharmaceuticals | 7 November 2017 |
| 1 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 72485-105-01 | Armas Pharmaceuticals | 27 March 2020 |
| 1 vial in 1 carton / 2 mL in 1 vial | 71839-120-01 | BE Pharmaceuticals | 12 July 2021 |
| 1 vial in 1 carton / 2 mL in 1 vial | 14335-131-01 | Hainan Poly Pharm | 13 August 2024 |
| 1 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 71288-202-02 | Meitheal Pharmaceuticals | 6 December 2019 |
| 1 vial in 1 carton / 2 mL in 1 vial | 70436-028-80 | Slate Run Pharmaceuticals | 15 October 2020 |
| 1 vial in 1 carton / 2 mL in 1 vial | 70069-261-01 | Somerset Therapeutics | 17 August 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 10 May 1974 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Sodium nitroprusside
Clinical summary
Sodium nitroprusside is a vasodilator indicated for immediate reduction of blood pressure, among other approved uses. It is available as injection for intravenous use. MedsAcross supplies Sodium nitroprusside for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Sodium nitroprussideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- NIPRIDE RTU prescribing information (Exela Pharma Sciences) · U.S. National Library of Medicine, DailyMed
Need Sodium nitroprusside 50 mg/2 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.